Home › Hypoparathyroidism
Hypoparathyroidism clinical trials recruiting in the U.S.
8 studies for Hypoparathyroidism are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07699471Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 16, 2026 · NCT07805356A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07081997A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
RecruitingObservational study
Ages 18 to 50 · Women · Updated Aug 7, 2026 · NCT07264634Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated May 7, 2026 · NCT07083557A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding
RecruitingObservational study
Ages 15 to 50 · Women · Updated Mar 2, 2026 · NCT07345494Parathyroid Allotransplant for Treatment of Hypoparathyroidism
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT06961071Hypoparathyroidism Natural History Study
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Dec 16, 2025 · NCT05793853From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.